Kindstar Globalgene Technology, Inc. (SEHK: 9960)
Health Care · Health Care Providers & Services · CN
HK$0.92
-0.54% today · -38.3% 1Y
Kindstar Globalgene Technology, Inc. (SEHK: 9960) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $116.89M and employs 3,100 people.
Over the last twelve months the share price has lost 38.3%, trading between 0.91 and 1.67.
Tweenvest scores Kindstar Globalgene Technology, Inc. across four factors: quality 62/100, value 66/100, growth 7/100, dividend 32/100. Its strongest factor is value.
9960 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $116.89M
- Revenue (TTM)
- $133.47M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- 10.27%
- Beta (5Y)
- 0.63
- 52-week high
- HK$1.67
- 52-week low
- HK$0.91
- Avg volume (3M)
- —
- Shares outstanding
- 995.66M
- Employees
- 3,100
- Next earnings
- —
About Kindstar Globalgene Technology, Inc.
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and pharmaceutical firms. This broad service portfolio is underpinned by its extensive, state-of-the-art laboratory infrastructure, which encompasses disciplines such as flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, and microbiology, alongside dedicated scientific research labs. Kindstar Global offers a comprehensive range of diagnostic tests covering key areas like hematology (blood), oncology (tumor), and genetic disorders. Its capabilities also extend to diseases affecting the cardiovascular and cerebrovascular systems, infectious agents, and autoimmune conditions, supporting various medical specialties including internal medicine, surgery, gynecology, pediatrics, and numerous other clinical fields. Established in 2003, the company maintains its headquarters in Wuhan, China.
- ISIN
- KYG5262E1044
- Founded
- 2003
- Listed since
- Jul 16, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $396.55 | -0.55% |
| CVS Health CorporationNYSE: CVS | $120.36B | $93.02 | -1.16% |
| McKesson CorporationNYSE: MCK | $101.88B | $884.41 | +1.22% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $427.86 | -0.32% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $400.83 | -0.45% |
| The Cigna GroupNYSE: CI | $74.11B | $277.30 | -1.12% |
| Cencora, Inc.NYSE: COR | $61.78B | $322.98 | -0.24% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $233.86 | +0.64% |
Figures last refreshed Aug 18, 2026.